LifeMD Inc. (NASDAQ:LFMD) finished Wednesday with an addition of $0.75 to close at $4.41, an upside of 20.63 percent. An average of 333,485 shares of common stock have been traded in the last five days. There was a gain of $0.09 in the past week, and it reached a new high 11 times over the past 12 months. The last 20 days have seen an average of 490,711 shares traded, while the 50-day average volume stands at 440,695.
LFMD stock has decreased by -6.06% in the last month. The company shares reached their 1-month lowest point of $3.31 on 07/20/23. With the stock rallying to its 52-week high on 07/11/23, shares of the company touched a low of $1.14 and a high of $5.45 in 52 weeks. It has reached a new high 22 times so far this year and achieved 127.58% or $2.37 in price. In spite of this, the price is down -18.99% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
LifeMD Inc. (LFMD) stock’s beta is 1.71. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.14.
Financial Health
The quick ratio of LifeMD Inc. for the three months ended June 29 was 0.60, and the current ratio was 0.70, indicating that the company is not able to meet its debt obligations. Its gross profit as reported stood at $100.37 million compared to revenue of $119.03 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, LifeMD Inc.’s return on assets was -120.30%.
Earnings Surprise
For the three-month period that ended June 29, LifeMD Inc. had $0.25 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$4.79 million in the quarter, while revenues were shrunk -296.24%. The analyst consensus anticipated LifeMD Inc.’s latest quarter earnings to come in at -$0.1 per share, but it turned out to be -$0.23, a -130.00% surprise. For the quarter, EBITDA amounted to -$1.45 million. At the end of the quarter ending June 29, LifeMD Inc.’s stock balance sheet showed total liabilities of 41.23 million. Shareholders own equity worth $32.41 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at LifeMD Inc. (LFMD) price momentum. RSI 9-day as of the close on 09 August was 55.26%, suggesting the stock is Neutral, with historical volatility in this time frame at 185.44%.
As of today, LFMD’s price is $3.99 +2.13% or $0.09 from its 5-day moving average. LFMD is currently trading -3.58% lower than its 20-day SMA and +274.78% higher than its 100-day SMA. However, the stock’s current price level is +105.24% above the SMA50 and +99.54% above the SMA200.
The stochastic %K and %D were 36.26% and 36.93%, respectively, and the average true range (ATR) was 0.46. With the 14-day stochastic at 63.70% and the average true range at 0.46, the RSI (14) stands at 54.46%. The stock has reached -0.27 on the 9-day MACD Oscillator while the 14-day reading was at -0.19.
Analyst Ratings
Cantor Fitzgerald launched coverage on LifeMD Inc. (NASDAQ: LFMD) in its analyst report released on July 21, 2023. The firm assigned the stock an Overweight rating. The consensus rating for LifeMD Inc. (LFMD) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell LFMD, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is LFMD’s price target for the next 12 months?
Analysts predict a range of price targets between $7.00 and $9.00, with a median target of $7.00. Taking a look at these predictions, the average price target given by analysts for LifeMD Inc. (LFMD) stock is $7.50.
